Vicplas International Ltd (SGX:569) entered into a non-binding term sheet to acquire 19% stake in XentiQ Partners Pte Ltd from Tan Eng Khian Eugene and Ulrich Johannes Schraudolph for SGD 0.4 million in cash on August 14, 2015. Vicplas International will acquire 0.02 million shares of XentiQ Partners from Tan Eng Khian Eugene and Ulrich Johannes Schraudolph in equal proportions. The aggregate consideration payable by Vicplas for the shares shall be payable to Tan Eng Khian Eugene and Ulrich Johannes Schraudolph in equal proportions on the completion of the deal. In related deal, Vicplas International Ltd entered into a non-binding term sheet to acquire 81% stake in XentiQ Pte. Ltd. from Tan Eng Khian Eugene and Ulrich Johannes Schraudolph on August 14, 2015. The deal is subject to satisfactory completion of all legal, financial, operational, technical and such related due diligence in relation to XentiQ Partners required by Vicplas International, the delivery to Vicplas of the business plans of XentiQ Partners relating to such medical devices and healthcare projects as specified by Vicplas, the passing of a resolution of the Board of Directors of Vicplas to approve the XentiQ Partners transaction and the relevant transaction documents, definitive share purchase agreement to be signed any other conditions as may be deemed necessary. Vicplas International Ltd (SGX:569) completed the acquisition of 19% stake in XentiQ Partners Pte Ltd from Tan Eng Khian Eugene and Ulrich Johannes Schraudolph during the second half of 2016.